Immunology / Virology & Vaccines

Stem cells
#Biologics / Biotechnology #Immunology / Virology & Vaccines #Stem cells

Podcast: Is customisation healthcare’s secret weapon? 

This is the latest episode of the free DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW.  The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual… Read More

#News

Stem cells
#Biologics / Biotechnology #Immunology / Virology & Vaccines #Narrated podcasts #Stem cells

Is customisation healthcare’s secret weapon? 

This is the latest episode of the free narrated DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Optimising vaccine production through… Read More

#Podcasts

#Immunology / Virology & Vaccines #Research #Vaccine candidate

Research shows social media can improve vaccination rates 

New research from the International Longevity Centre (ILC) in London, UK, finds that social media advertising can be a cost-effective way of engaging older people in deprived communities with vaccination.  The approach  In the past, researchers found that older people are less likely to use… Read More

#News #Trending News

#Covid-19 #Immunology / Virology & Vaccines #Market reporting

Was England’s vaccine programme value for money?

This most recent report by the Comptroller and Auditor General examines the rollout of the Covid-19 vaccination programme in England up to the end of October 2021, focusing on events up to the end of October 2021 and assessing whether the programme is well placed to meet its objectives… Read More

#Covid-19 #News

#Antimicrobials #Bioconvergence #Drug development #Immunology / Virology & Vaccines #mRNA

Bioconvergence: Future trends for biomedicine

Dr. Tom Knapman, Director of Strategic Brand at SCIEX, explains how bioconvergent advances will help to drive key health trends in the coming year. As we move into 2022, we will see more and more advances in bioconvergence – biological, physical, and computing technologies inspired by nature. We expect these… Read More

#Exclusive Content #News #Opinion #Trending News #Trends & Analysis

#Cancer research #Immunology / Virology & Vaccines #Whitepaper

Cancer vaccine white paper from Frost and Sullivan industry experts

In this white paper, brought to you by BioRad, hear from leading industry experts in the emerging field of cancer vaccines. The experts discuss: Challenges related to antigen and adjuvant selection Vaccine design Immune response improvement Future treatment options Download the white paper here. Read More

#News

#Covid-19 #FDA #Immunology / Virology & Vaccines #Moderna

Moderna receives full FDA approval for Covid-19 vaccine Spikevax 

The US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Moderna’s Spikevax, an mRNA vaccine for prevention of Covid-19 in individuals 18 years of age and older.  Official comments   “Our Covid-19 vaccine has been administered to hundreds of millions of… Read More

#News

#Covid booster #Covid variants #Covid-19 #Immunology / Virology & Vaccines #Moderna #mRNA #Omicron

Moderna begins Omicron booster trial and presents durability data 

Moderna has dosed the first participant in a Phase II study of the company’s Omicron-specific booster candidate (mRNA-1273.529). Additionally, Moderna announced the publication of neutralising antibody data against the Omicron variant six months following a booster dose in The New England Journal of Medicine.   The mRNA-1273.529 trial  This extension… Read More

#News #Trending News

#Antigen #Biotechnology #Immunology / Virology & Vaccines #mRNA #RNA #Therapeutics

What’s next for RNA-based medicine post-Covid-19?

Dr Pirkko Muhonen, Senior Field Application Scientist, Nucleic Acid Therapeutics, at Thermo Fisher Scientific, shares what's next for RNA-based medicine post-pandemic with DDW. With SARS-CoV-2 circulating the globe and leading to over five million deaths worldwide1, all eyes are on the critical role messenger RNA (mRNA) vaccines are playing in… Read More

#Covid-19 #Exclusive Content #News #Trends & Analysis

#Covid booster #Covid-19 #FDA #Immunology / Virology & Vaccines #mRNA

Additional dose of Covid-19 vaccine is safe, says US trial 

A study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, suggests that an additional dose of a Covid-19 vaccine is safe in adults who had previously received a full regimen of any of three Covid-19 vaccines granted Emergency Use Authorization… Read More

#News #Trending News

#Covid booster #Covid variants #Covid-19 #Immunology / Virology & Vaccines #Omicron

Covid-19 booster provides good antibody protection against Omicron 

A third ‘booster’ dose of Covid-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published as a Research letter in The Lancet.   The results  Researchers found that antibodies generated in people… Read More

#News

RNA
#CAR-T #Immunology / Virology & Vaccines #mRNA #T-Cells

Vaccine-like mRNA injection can be used to make CAR-T cells 

A study from researchers in the Perelman School of Medicine at the University of Pennsylvania has shown that an experimental immunotherapy can temporarily reprogramme patients’ immune cells to attack a specific target via only a single injection of mRNA, similar to the mRNA-based Covid-19 vaccines.  Context  The researchers, whose… Read More

#News

#Collaboration #Drug development #Immunology / Virology & Vaccines #mRNA

Pfizer and BioNTech develop first mRNA-based shingles vaccine

Pfizer and BioNTech have announced a new research, development and commercialisation collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), which impacts about one in three people in the US during their lifetime.   Why now?  The collaboration… Read More

#News

#Covid booster #Covid-19 #Immunology / Virology & Vaccines #Omicron #RNA #T-Cells

Early data for multivariant Covid-19 vaccine booster shows promise  

The first results of an early trial of a multivariant Covid-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.  The results  US-based biotechnology company Gritstone bio, in collaboration with The University of Manchester and Manchester University… Read More

#Covid-19 #News

#Antibodies #Clinical trials #HIV #Immunology / Virology & Vaccines #mRNA

Experimental mRNA HIV vaccine is safe and shows promise in animals 

An experimental HIV vaccine based on mRNA shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results The results, published in Nature Medicine, show that the novel vaccine was safe and… Read More

#News